Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Lindsay B Kilburn; Dong-Anh Khuong-Quang; Jordan R Hansford; Daniel Landi; Jasper van der Lugt; Sarah E S Leary; Pablo Hernáiz Driever; Simon Bailey; Sébastien Perreault; Geoffrey McCowage; Angela J Waanders; David S Ziegler; Olaf Witt; Patricia A Baxter; Hyoung Jin Kang; Timothy E Hassall; Jung Woo Han; Darren Hargrave; Andrea T Franson; Michal Yalon Oren; Helen Toledano; Valérie Larouche; Cassie Kline; Mohamed S Abdelbaki; Nada Jabado; Nicholas G Gottardo; Nicolas U Gerber; Nicholas S Whipple; Devorah Segal; Susan N Chi; Liat Oren; Enrica E K Tan; Sabine Mueller; Izzy Cornelio; Lisa McLeod; Xin Zhao; Ashley Walter; Daniel Da Costa; Peter Manley; Samuel C Blackman; Roger J Packer; Karsten Nysom

doi:10.1038/s41591-024-02910-1

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Lindsay B Kilburn^*, Dong-Anh Khuong-Quang, Jordan R Hansford, Daniel Landi, Jasper van der Lugt, Sarah E S Leary, Pablo Hernáiz Driever, Simon Bailey, Sébastien Perreault, Geoffrey McCowage, Angela J Waanders, David S Ziegler, Olaf Witt, Patricia A Baxter, Hyoung Jin Kang, Timothy E Hassall, Jung Woo Han, Darren Hargrave, Andrea T Franson, Michal Yalon OrenHelen Toledano, Valérie Larouche, Cassie Kline, Mohamed S Abdelbaki, Nada Jabado, Nicholas G Gottardo, Nicolas U Gerber, Nicholas S Whipple, Devorah Segal, Susan N Chi, Liat Oren, Enrica E K Tan, Sabine Mueller, Izzy Cornelio, Lisa McLeod, Xin Zhao, Ashley Walter, Daniel Da Costa, Peter Manley, Samuel C Blackman, Roger J Packer, Karsten Nysom

^*Corresponding author af dette arbejde

Afdeling for Børn og Unge JMC

2 Citationer (Scopus)

Originalsprog	Engelsk
Publikationsdato	maj 2024
Udgave	5
Vol/bind	30
Antal sider	1
DOI	https://doi.org/10.1038/s41591-024-02910-1
Status	Udgivet - maj 2024

Navn	Nature Medicine
ISSN	1078-8956

Adgang til dokumentet

10.1038/s41591-024-02910-1Licens: CC BY

Andre filer og links

Link to publication in Scopus

Citationsformater

Kilburn, L. B., Khuong-Quang, D.-A., Hansford, J. R., Landi, D., van der Lugt, J., Leary, S. E. S., Driever, P. H., Bailey, S., Perreault, S., McCowage, G., Waanders, A. J., Ziegler, D. S., Witt, O., Baxter, P. A., Kang, H. J., Hassall, T. E., Han, J. W., Hargrave, D., Franson, A. T., ... Nysom, K. (2024, maj). Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. (5 udg.) Nature Medicine https://doi.org/10.1038/s41591-024-02910-1

Kilburn, LB, Khuong-Quang, D-A, Hansford, JR, Landi, D, van der Lugt, J, Leary, SES, Driever, PH, Bailey, S, Perreault, S, McCowage, G, Waanders, AJ, Ziegler, DS, Witt, O, Baxter, PA, Kang, HJ, Hassall, TE, Han, JW, Hargrave, D, Franson, AT, Yalon Oren, M, Toledano, H, Larouche, V, Kline, C, Abdelbaki, MS, Jabado, N, Gottardo, NG, Gerber, NU, Whipple, NS, Segal, D, Chi, SN, Oren, L, Tan, EEK, Mueller, S, Cornelio, I, McLeod, L, Zhao, X, Walter, A, Da Costa, D, Manley, P, Blackman, SC, Packer, RJ & Nysom, K 2024, Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.. https://doi.org/10.1038/s41591-024-02910-1

@misc{2f0c98365896470cb8369cc40a43d0ef,

title = "Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial",

author = "Kilburn, \{Lindsay B\} and Dong-Anh Khuong-Quang and Hansford, \{Jordan R\} and Daniel Landi and \{van der Lugt\}, Jasper and Leary, \{Sarah E S\} and Driever, \{Pablo Hern{\'a}iz\} and Simon Bailey and S{\'e}bastien Perreault and Geoffrey McCowage and Waanders, \{Angela J\} and Ziegler, \{David S\} and Olaf Witt and Baxter, \{Patricia A\} and Kang, \{Hyoung Jin\} and Hassall, \{Timothy E\} and Han, \{Jung Woo\} and Darren Hargrave and Franson, \{Andrea T\} and \{Yalon Oren\}, Michal and Helen Toledano and Val{\'e}rie Larouche and Cassie Kline and Abdelbaki, \{Mohamed S\} and Nada Jabado and Gottardo, \{Nicholas G\} and Gerber, \{Nicolas U\} and Whipple, \{Nicholas S\} and Devorah Segal and Chi, \{Susan N\} and Liat Oren and Tan, \{Enrica E K\} and Sabine Mueller and Izzy Cornelio and Lisa McLeod and Xin Zhao and Ashley Walter and \{Da Costa\}, Daniel and Peter Manley and Blackman, \{Samuel C\} and Packer, \{Roger J\} and Karsten Nysom",

year = "2024",

month = may,

doi = "10.1038/s41591-024-02910-1",

language = "English",

volume = "30",

series = "Nature Medicine",

publisher = "Nature Research",

edition = "5",

type = "Other",

}

TY - GEN

T1 - Author Correction

T2 - The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

AU - Kilburn, Lindsay B

AU - Khuong-Quang, Dong-Anh

AU - Hansford, Jordan R

AU - Landi, Daniel

AU - van der Lugt, Jasper

AU - Leary, Sarah E S

AU - Driever, Pablo Hernáiz

AU - Bailey, Simon

AU - Perreault, Sébastien

AU - McCowage, Geoffrey

AU - Waanders, Angela J

AU - Ziegler, David S

AU - Witt, Olaf

AU - Baxter, Patricia A

AU - Kang, Hyoung Jin

AU - Hassall, Timothy E

AU - Han, Jung Woo

AU - Hargrave, Darren

AU - Franson, Andrea T

AU - Yalon Oren, Michal

AU - Toledano, Helen

AU - Larouche, Valérie

AU - Kline, Cassie

AU - Abdelbaki, Mohamed S

AU - Jabado, Nada

AU - Gottardo, Nicholas G

AU - Gerber, Nicolas U

AU - Whipple, Nicholas S

AU - Segal, Devorah

AU - Chi, Susan N

AU - Oren, Liat

AU - Tan, Enrica E K

AU - Mueller, Sabine

AU - Cornelio, Izzy

AU - McLeod, Lisa

AU - Zhao, Xin

AU - Walter, Ashley

AU - Da Costa, Daniel

AU - Manley, Peter

AU - Blackman, Samuel C

AU - Packer, Roger J

AU - Nysom, Karsten

PY - 2024/5

Y1 - 2024/5

UR - https://www.scopus.com/pages/publications/85187117033

U2 - 10.1038/s41591-024-02910-1

DO - 10.1038/s41591-024-02910-1

M3 - Other contribution

C2 - 38467878

VL - 30

T3 - Nature Medicine

ER -